AnorMed raises C$21.3 million

AnorMed (TSE:AOM), a developer of

Read the full 52 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE